John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 20,000 shares at $41.58 ($880K) on 2014-12-08, disclosed to the SEC on 2014-12-09.
Scheduled sale ($880k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.43 | 400 | $15K | 1.7% |
| 2 | $40.55 | 800 | $32K | 3.7% |
| 3 | $41.58 | 400 | $17K | 1.9% |
| 4 | $42.90 | 5,413 | $232K | 26.4% |
| 5 | $44.35 | 7,036 | $312K | 35.5% |
| 6 | $45.10 | 4,300 |
| $194K |
| 22.0% |
| 7 | $46.54 | 1,200 | $56K | 6.3% |
| 8 | $47.45 | 451 | $21K | 2.4% |
| Total | $43.99 avg | 20,000 | $880K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |